Belite Bio Inc

BLTE | NASDAQ

Price Alert Chart Builder DCF Calculator

$176.43

+$3.03 (+1.75%)

Sep 22, 2026, 10:51 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 May 30, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-34.91M	-32.68M	-28.08M	-23.02M	-17.6M	-15.52M	-11.46M	-9.74M	-10.47M	-8.33M	-6.96M	-10.96M	-6.87M	-6.88M	-6.72M	-2.54M	-2.51M	-1.05M	-2.5M	-2.5M	-2.4M	-2.4M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.50	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-28.36M	-26.94M	-25.32M	-21.69M	-16.32M	-14.28M	-10.1M	-8.68M	-9.49M	-7.87M	-6.99M	-10.93M	-6.81M	-6.89M	-6.78M	-2.4M	-2.39M	-1.07M	-2.47M	-2.47M	-2.36M	-2.36M
Net Income	-28.41M	-26.94M	-25.32M	-21.69M	-16.32M	-14.28M	-10.1M	-8.68M	-9.49M	-7.87M	-6.99M	-10.94M	-6.81M	-6.9M	-6.78M	-2.4M	-2.39M	-1.07M	-2.47M	-2.47M	-2.36M	-2.36M
Selling & General & Admin	16.69M	17.02M	13.45M	12.71M	6.55M	6.12M	4.2M	2.9M	1.39M	1.56M	2.09M	2.22M	1.36M	1.16M	1.5M	1.36M	927K	175K	610K	610K	579K	579K
Research & Development	18.21M	15.66M	14.63M	10.31M	11.05M	9.4M	7.25M	6.84M	9.08M	6.77M	4.86M	8.74M	5.52M	5.72M	5.23M	1.19M	1.58M	878K	1.89M	1.89M	1.82M	1.82M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	34.91M	32.68M	28.08M	23.02M	17.6M	15.52M	11.46M	9.74M	10.47M	8.33M	6.96M	10.96M	6.87M	6.88M	6.72M	2.54M	2.51M	1.05M	2.5M	2.5M	2.4M	2.4M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	32.75K	n/a	n/a	n/a	500	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	34.91M	32.68M	28.08M	23.02M	17.6M	15.52M	11.46M	9.74M	10.47M	8.33M	6.96M	10.96M	6.87M	6.88M	6.72M	2.54M	2.51M	1.05M	2.5M	2.5M	2.4M	2.4M
Income Tax Expense	55K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	6K	-1K	1K	3K	6K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	40.18M	39.87M	33.54M	33.22M	32.59M	32.08M	31.45M	30.69M	30.32M	29.68M	28.32M	27.32M	25.79M	20.95M	22.42M	24.87M	19.66M	24.1M	9.57M	9.57M	9.57M	9.57M
Shares Outstanding (Diluted)	40.18M	39.87M	33.54M	33.22M	32.59M	32.08M	31.45M	30.69M	30.32M	29.68M	28.32M	27.32M	25.79M	20.95M	22.42M	24.87M	19.66M	24.1M	9.57M	9.57M	9.57M	9.57M
EPS (Basic)	-0.71	-0.68	-0.72	-0.65	-0.50	-0.44	-0.32	-0.28	-0.31	-0.27	-0.25	-0.40	-0.26	-0.33	-0.30	-0.10	-0.12	-0.04	-0.26	-0.26	-0.25	-0.25
EPS (Diluted)	-0.71	-0.68	-0.72	-0.65	-0.50	-0.44	-0.32	-0.28	-0.31	-0.27	-0.25	-0.40	-0.26	-0.33	-0.30	-0.10	-0.12	-0.04	-0.26	-0.26	-0.25	-0.25
EBITDA	-34.91M	-26.94M	-30.68M	-21.69M	-16.28M	-14.24M	-7.58M	-8.64M	-9.46M	-7.83M	-6.89M	-10.92M	-6.81M	-6.89M	-6.53M	-2.4M	-2.39M	-1.07M	-2.46M	-2.47M	-2.35M	-2.39M
EBIT	-34.91M	-26.94M	-30.68M	-21.69M	-16.32M	-14.28M	-7.58M	-8.68M	-9.49M	-7.87M	-6.89M	-10.93M	-6.81M	-6.89M	-6.53M	-2.4M	-2.39M	-1.07M	-2.47M	-2.47M	-2.36M	-2.4M
Depreciation & Amortization	n/a	n/a	117	n/a	42K	42K	n/a	34.75K	34.75K	34.75K	n/a	16K	n/a	n/a	n/a	n/a	n/a	n/a	7.5K	7.5K	7.5K	7.5K